home / stock / vlns / vlns news


VLNS News and Press, The Valens Company Inc. From 04/05/22

Stock Information

Company Name: The Valens Company Inc.
Stock Symbol: VLNS
Market: NASDAQ
Website: thevalenscompany.com

Menu

VLNS VLNS Quote VLNS Short VLNS News VLNS Articles VLNS Message Board
Get VLNS Alerts

News, Short Squeeze, Breakout and More Instantly...

VLNS - The Valens Company Closes Previously Announced Bought Deal Financing Including Exercise of Over-Allotment Option

The Valens Company Closes Previously Announced Bought Deal Financing Including Exercise of Over-Allotment Option Canada NewsWire KELOWNA, BC , April 5, 2022 /CNW/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the " Company ," " The Valens Company ...

VLNS - AKBA, TMC and ISIG among mid-day movers

Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....

VLNS - Adagio, Vyant Bio top healthcare gainers; while Revelation, UpHealth lead losers' pack

Gainers: Adagio Therapeutics (ADGI) +48%. Vyant Bio (VYNT) +23%. Vir Biotechnology (VIR) +19%. Sonoma Pharmaceuticals (SNOA) +15%. Syros Pharmaceuticals (SYRS) +15%. Losers: Revelation Biosciences (REVB) -40%. UpHealth (UPH) -29%. The Valens (VLNS)...

VLNS - Valens announces C$28.1M bought deal offering of units

Valens (NASDAQ:VLNS) said a syndicate of underwriters will purchase, on a "bought deal" basis, 10.6M units of the company at C$2.65/unit for total gross proceeds of C$28.1M. Each unit will be comprised of 1 share and 1/2 of a share purchase warrant. Each warrant will be exercisable to acquire...

VLNS - The Valens Company Announces Approximately USD$22.5 Million Bought Deal Offering of Units

The Valens Company Announces Approximately USD$22.5 Million Bought Deal Offering of Units Canada NewsWire KELOWNA, BC , March 29, 2022 /CNW/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the " Company ", " The Valens Company " or " ...

VLNS - The Valens Company Continues to Grow National Market Share

The Valens Company Continues to Grow National Market Share PR Newswire KELOWNA, BC , March 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis product...

VLNS - Taking Advantage Of Market Volatility? 3 Marijuana Penny Stocks To Watch In March

Best Cannabis Stocks To Watch For Active Traders Are you looking for the best marijuana stocks to buy in this market volatility? Since February 2021 the top cannabis stocks to buy have experienced significant declines in the market. This is mostly associated with the delays with fed...

VLNS - Green Roads Announces Support for the Arthritis Foundation and Launch of an Arthritis Pain Relief Roll-On

DEERFIELD BEACH, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Green Roads , a leading CBD wellness brand and subsidiary of The Valens Company, announced today they are an official Supporting Sponsor of the Arthritis Foundation after giving a $120,000 donation to support the organization...

VLNS - The Valens Company Inc. (VLNS) CEO Tyler Robson on Q4 2021 Results - Earnings Call Transcript

The Valens Company Inc. (VLNS) Q4 2021 Earnings Conference Call March 1, 2022, 11:00 AM ET Company Participants Everett Knight - Executive VP, Corporate Development and Capital Markets Tyler Robson - Chairman and CEO Jeffrey Fallows - President Sunil Gandhi - CFO Conference Call Participants ...

VLNS - Valens Predicts Sales Will Double To $225 Million in 2023

After the market closed on Monday, The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) delivered its fourth quarter and fiscal year financial results for the period ending November 30, 2021 . Valens reported total revenue of $23.3 million for the fourth quarter,...

Previous 10 Next 10